Skip to content

PTSD research published in 2024

Page 5 of 5: studies 81 to 95 of 95, newest first. Back to the PTSD overview

Studies

Half a Century of Research on Posttraumatic Stress Disorder: A Scientometric Analysis.

Current Neuropharmacology 2024 Michel Sabé, Chaomei Chen, Wissam El-Hage et al. 25 citations

We conducted a scientometric analysis to outline clinical research on posttraumatic stress disorder (PTSD). Our primary objective was to perform a broad-ranging scientometric analysis to evaluate key themes and trends over the past decades. Our secondary objective was to measure research network performance. We conducted a systematic search in the Web of Science Core Collection up to 15 August...

Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder.

European Journal of Psychotraumatology 2024 Richard J. Zeifman, Hannes Kettner, Stephen Ross et al. 34 citations

Background: MDMA-assisted psychotherapy (MDMA-AP) is a combined psychotherapeutic and pharmacologic intervention that shows promise in the treatment of posttraumatic stress disorder (PTSD). Although therapeutic alliance has been established as a key predictor across psychotherapies and is emphasised within MDMA-AP treatment manuals, research has not yet examined the relationship between...

DOI: 10.1080/20008066.2023.2297536 (opens in new tab) Full text (opens in new tab) MDMA-Assisted Psychotherapy Posttraumatic stress disorder Alianza terapéutica Mecanismos de cambio +2

The effects of a combination of cognitive interventions and loving-kindness meditations (C-METTA) on guilt, shame and PTSD symptoms: results from a pilot randomized controlled trial.

European Journal of Psychotraumatology 2024 Meike Müller-Engelmann, Luisa Bahnemann, Stella Kümmerle 5 citations

Background: Trauma-related guilt and shame are crucial for the development and maintenance of PTSD (posttraumatic stress disorder). We developed an intervention combining cognitive techniques with loving-kindness meditations (C-METTA) that specifically target these emotions. C-METTA is an intervention of six weekly individual treatment sessions followed by a four-week practice phase.Objective:...

DOI: 10.1080/20008066.2024.2308439 (opens in new tab) Full text (opens in new tab) PTSD Intervenciones cognitivas Tept Cognitive interventions +3

Trends in waking salivary alpha-amylase levels following healing lucid dreams.

Frontiers in Psychology 2024 Garret Yount, Sitara Taddeo, Tadas Stumbrys et al. 1 citation

Salivary alpha-amylase (sAA) is considered a marker of autonomic nervous system activity in stress research, and atypical waking sAA responses have been reported for traumatized individuals. Lucid dreams, characterized by a dreamer's awareness of their dream state while remaining asleep, have shown promising preliminary evidence of their potential to enhance mental health. This study's...

Prevalence and Clinical Characteristics of Sleeping Paralysis: A Systematic Review and Meta-Analysis.

Cureus 2024 Mahmoud T Hefnawy, Basma E Amer, Samar A Amer et al. 8 citations

Sleep paralysis (SP) is a mixed state of consciousness and sleep, combining features of rapid eye movement (REM) sleep with those of wakefulness. The exact cause of SP is unknown, and its prevalence varies among the studies. We aim to identify SP's global prevalence, the affected population's characteristics, and the SP's clinical picture. We searched three databases (PubMed, Scopus, and Web of...

DOI: 10.7759/cureus.53212 (opens in new tab) Full text (opens in new tab) PTSD Hallucinations Isolated sleep paralysis Isp +2

The effectiveness of mindfulness-based stress reduction (MBSR) on depression, PTSD, and mindfulness among military veterans: A systematic review and meta-analysis.

Health Psychology Open 2024 Wendy Wen Li, Jaime Nannestad, Timothy Leow et al. 19 citations

Thirteen studies were included in the current systematic review and meta-analysis with 1131 participants. Both within- and between-group comparisons demonstrated reductions in depressive and PTSD symptoms with medium effect sizes post MBSR intervention. Additionally, MBSR demonstrated small effects in improving mindfulness in veterans at post-intervention. Maintenance of treatment effects were...

Psilocybin for the treatment of posttraumatic stress disorder: A magic to treat a harmony of illusions?

Journal of Indira Gandhi Institute Of Medical Sciences 2024 Rakesh Khanna 1 citation

Abstract A review of the literature on posttraumatic stress disorder (PTSD) suggests it to be a complex disorder with many contributing factors. The concept of PTSD has continued to evolve over time. A diagnosis of PTSD may be hard to get right. Studies suggest a wide variation in its presentation and diagnostic stability. It is tempting to explore the possibility of using chemicals that could...

DOI: 10.4103/jigims.jigims_60_23 (opens in new tab) Psilocybin Psychedelic-assisted therapy Diagnostic uncertainties Posttraumatic stress disorder +1

Ketamine in the effective management of chronic pain, depression, and posttraumatic stress disorder for Veterans: A meta-analysis and systematic review.

Frontiers in Psychiatry 2024 Jenny J W Liu, Natalie Ein, Julia Gervasio et al. 13 citations

Ketamine has emerged as a promising treatment alternative for the management of chronic pain. Despite encouraging findings in civilian populations, and favourable results from trials examining its efficacy in military populations, there is still a dearth of information pointing to optimal specifications related to ketamine administration for pain, depression, and posttraumatic stress disorder...

DOI: 10.3389/fpsyt.2024.1338581 (opens in new tab) Full text (opens in new tab) Mental health Veterans-military-servicemembers Mental-Health-PTSD-Depression-Trauma Ketamine-therapy-treatment +2

Expert opinions on implementation of MDMA-assisted therapy in Europe: critical appraisal towards training, clinical practice, and regulation.

European Journal of Psychotraumatology 2024 Jerome Herpers, Natalie Maximets, Noah N N van Dongen et al. 7 citations

Introduction: The positive results of MDMA from Phase 2 and 3 clinical trials in MDMA-assisted therapy (MDMA-AT) for the treatment of post-traumatic stress disorder (PTSD) call for a critical evaluation of its regulatory status within the European mental healthcare system. This is driven by the recent submission of MDMA-AT for FDA approval in the United States. Unless coordinated efforts in the...

Including Sexually and Gender Diverse Populations in 3,4-Methylenedioxymethamphetamine-Assisted Psychotherapy Trial Research.

LGBT health 2024 Ziad Saade, Brady D. Hanshaw, Alex S Keuroghlian 3 citations

Sexually and gender diverse (SGD) populations experience an increased prevalence and severity of posttraumatic stress disorder (PTSD) compared with the general population. Minority stress theory contextualizes this increased disease burden by outlining how stigma and discrimination (e.g., homophobia and transphobia) contribute to worse mental health outcomes. The standard-of-care...

Cost-effectiveness of midomafetamine-assisted therapy (MDMA-AT) in chronic and treatment-resistant post-traumatic stress disorder of moderate or higher severity: A health-economic model.

PLoS One 2024 Filip Stanicic, Vladimir Zah, Dimitrije Grbic et al. 4 citations

To explore the cost-effectiveness of midomafetamine-assisted therapy (MDMA-AT) compared to placebo with therapy (PT) in US healthcare settings. A health state-transition model was used to analyze the cost-effectiveness of MDMA-AT for treating patients with chronic PTSD of moderate or higher severity. Both treatment arms consisted of 3 preparation (90-min), 3 interventional (8-h), and 9...

DOI: 10.1371/journal.pone.0313569 (opens in new tab) Full text (opens in new tab) MDMA Therapy Mental health economics PTSD Treatment Healthcare costs +1

The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSD.

Frontiers in Psychology 2024 Kelley C O'Donnell, Lauren Okano, Michael Alpert et al.

Results from multiple recent studies support further evaluation of 3,4-methylenedioxymethamphetamine (MDMA) in conjunction with psychotherapy (i.e., MDMA-Assisted Therapy) in the treatment of post-traumatic stress disorder (PTSD). In two Phase 3 trials, MDMA-Assisted Therapy comprised a short-term, intensive psychotherapy that included three sessions directly facilitated by MDMA (referred to as...

Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.

Neuropsychiatric Disease and Treatment 2024 Nadav Liam Modlin, Michael Creed, Maria Sarang et al. 18 citations

Post-traumatic stress disorder (PTSD) is associated with significant patient burden. While pharmacotherapies and evidence-based psychotherapy interventions (EBPI) are effective, studies consistently highlight inadequate outcomes and high treatment dropout. Psychedelic therapy (PT) has shown preliminary promise across difficult-to-treat conditions, including MDMA-assisted therapy for PTSD,...

Prospective associations of psychedelic treatment for co-occurring alcohol misuse and posttraumatic stress symptoms among United States Special Operations Forces Veterans.

Military psychology : the official journal of the Division of Military Psychology, American Psychological Association 2024 Stacey B. Armstrong, Yitong Xin, Nathan D. Sepeda et al. 19 citations

This study evaluated prospective associations of ibogaine and 5-MeO-DMT treatment for risky alcohol use and post-traumatic stress disorder (PTSD) symptoms among United States (US) Special Operations Forces Veterans (SOFV). Data were collected during standard clinical operations at pre-treatment and 1-month (1 m), 3-months (3 m), and 6-months (6 m) post-treatment in an ibogaine and 5-MeO-DMT...

DOI: 10.1080/08995605.2022.2156200 (opens in new tab) Full text (opens in new tab) Addiction treatment Psychedelic Special operations veterans Alcohol misuse +6

Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders.

Journal of addiction psychiatry 2024 Gianni Martire, Daniel Sipple, David Baron et al. 341 citations

Borderline personality disorder (BPD) and post-traumatic stress disorder (PTSD) share overlapping neurobiological mechanisms particularly reward deficiency and stress-like anti-reward processes. And so, BPD may be reclassified as a "traumatic personality stress disorder" (TPSD) with ensuing common therapeutic strategies that may stabilize dopaminergic reward function such as...